25D-NBOMe

25D-NBOMe
Clinical data
Other names	NBOMe-2C-D; 2C-D-NBOMe; 2,5-Dimethoxy-N-(2-methoxybenzyl)-4-methylphenethylamine; N-(2-Methoxybenzyl)-4-methyl-2,5-dimethoxyphenethylamine
Drug class	Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); DE: NpSG (Industrial and scientific use only); UK: Class A; Illegal in China and Sweden;
Identifiers
	IUPAC name 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine;
CAS Number	1354632-02-2;
PubChem CID	118536027;
ChemSpider	48059920 ;
UNII	7RET11HE13;
CompTox Dashboard (EPA)	DTXSID601014189 ;
Chemical and physical data
Formula	C19H25NO3
Molar mass	315.413 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=C(C=C(C(=C1)C)OC)CCNCC2=C(C=CC=C2)OC;
	InChI InChI=1S/C19H25NO3/c1-14-11-19(23-4)15(12-18(14)22-3)9-10-20-13-16-7-5-6-8-17(16)21-2/h5-8,11-12,20H,9-10,13H2,1-4H3 ; Key:UTVHBNXCFSATDB-UHFFFAOYSA-N ;

25D-NBOMe, also known as NBOMe-2C-D and "divination", is a derivative of the phenethylamine derived hallucinogen 2C-D. It acts in a similar manner to related compounds such as 25I-NBOMe, which is a potent agonist at the 5-HT_2A receptor. 25D-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe. It was banned as a Temporary Class Drug in the UK on 10 June 2013 after concerns about its recreational use.